Attila Csányi - Concepedia

Author

Attila Csányi

Also Known As

A Csanyi, A Csányi, A. Csanyi, A. Csányi, A.F. Csanyi, Attila CSANYI, Attila Csanyi, Attila Csányi, Attila Csányi, Csanyi, Attila

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Petz Aladár Megyei Oktató Kórház Université Paris Cité Vall d'Hebron Hospital Universitari Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház Hôpital Bichat-Claude-Bernard

About

Attila Csányi is an author at Petz Aladár Megyei Oktató Kórház specializing in medicine, cardiovascular disease, and rehabilitation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	288
2	Social Sciences	2	2	149
3	Biochemistry	2	2	90
4	Health Sciences	1	1	34
5	Public Health	1	1	49

Attila Csányi

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Journal of the American Heart Association	2016	196
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados, The Lancet Neurology	2018	177
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS Robert J. Fox, Andrew Chan, Ralf Gold, Neurology Clinical Practice	2016	104
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin Pierre Amarenco, Hans Denison, Scott Evans, Stroke	2020	98
Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of the Cortical Spreading Depression Inhibiting Agent Tonabersat in Migraine Prophylaxis Michel D. Ferrari, Attila Csányi, Jes Olesen, Cephalalgia Cluster HeadacheNeuromodulation (Medicine)PsychiatryNeurophysiologyPain Medicine	2009	97
Prophylaxis of Thrombotic and Embolic Events in Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin Hans‐Christoph Diener, E. Bernd Ringelstein, Rüdiger von Kummer, Stroke	2005	91
Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis István Karádi, Zsuzsa Mészáros, Attila Csányi, Clinica Chimica Acta InflammationMetabolic SyndromeVascular DiseaseCardiovascular DiseaseBiochemistry	2002	56
Probabilistic sequence learning in mild cognitive impairment Dezső Németh, Karolina Janacsek, Katalin Király, Frontiers in Human Neuroscience NeuropsychologyMachine LearningNeurolinguisticsSequential LearningGeneral Reaction Times	2013	52
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial Hugues Chabriat, Claudio L. Bassetti, Ute C. Marx, The Lancet Neurology ThrombosisNeurobiology Of DiseaseIschemic StrokeCardiovascular DiseaseMedicine	2020	49
Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke Pierre Amarenco, Hans Denison, Scott Evans, JAMA Neurology	2020	41

Page 1